Fluconazole in hypercalciuric patients with increased 1,25(OH)(2)D levels: the prospective, randomized, placebo-controlled, double-blind FLUCOLITH trial

BACKGROUND: Hypercalciuria is one of the most frequent metabolic disorders associated with nephrolithiasis and/or nephrocalcinosis possibly leading to chronic kidney disease (CKD) and bone complications in adults. Orphan diseases with different underlying primary pathophysiology share inappropriatel...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertholet-Thomas, Aurélia, Portefaix, Aurélie, Flammier, Sacha, Dhelens, Carole, Subtil, Fabien, Dubourg, Laurence, Laudy, Valérie, Le Bouar, Myrtille, Boussaha, Inesse, Ndiaye, Marietou, Molin, Arnaud, Lemoine, Sandrine, Bacchetta, Justine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204961/
https://www.ncbi.nlm.nih.gov/pubmed/35710560
http://dx.doi.org/10.1186/s13063-022-06302-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204961/
https://www.ncbi.nlm.nih.gov/pubmed/35710560
http://dx.doi.org/10.1186/s13063-022-06302-z

Ejemplares similares